GG 1978

Solarea Bio, Inc. is a biotech company based in Cambridge, Massachusetts, established in 2017. The company specializes in the development of microbial therapeutics aimed at addressing health issues related to chronic inflammation. By harnessing bacteria and fungi derived from healthy foods, Solarea creates synergistic microbial assemblages with anti-inflammatory properties. It maintains a comprehensive genomic database of these microbes and employs computational methods to generate combinations of bacteria, fungi, and prebiotic fibers tailored to treat specific conditions. Solarea's research has demonstrated the effectiveness of its products in preclinical models. Its initial focus is on dietary management solutions for metabolic processes associated with osteopenia and osteoporosis in postmenopausal women, providing a nature-based approach to enhance women's health and well-being.